PULSE BIOSCIENCES INC news, videos and press releases
For more news please use our advanced search feature.
PULSE BIOSCIENCES INC - More news...
PULSE BIOSCIENCES INC - More news...
- Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
- Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
- Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
- Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
- Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
- Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
- Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium
- Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer
- Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference
- Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
- Pulse Biosciences, Inc. Announces Election to Exercise Company Warrants
- Pulse Biosciences Announces Publication in the Journal of Thoracic and Cardiovascular Surgery
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Pulse Biosciences, Inc. (NASDAQ: PLSE)
- Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
- Pulse Biosciences Schedules Second Quarter 2023 Financial Results Conference Call for August 10, 2023
- Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting
- Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
- Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
- Pulse Biosciences, Inc. Appoints Dr. Gan Dunnington as Chief Medical Officer
- Pulse Biosciences Announces $65 Million Private Placement
- Pulse Biosciences Schedules First Quarter 2023 Financial Results Conference Call for May 11, 2023
- Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
- Pulse Biosciences Schedules Fourth Quarter & Full Year 2022 Financial Results Conference Call for March 30, 2023
- Pulse Biosciences Announces Its Novel Nanosecond Pulsed Field Ablation System Will Be Highlighted at the 2023 AF Symposium
- Pulse Biosciences Reports Third Quarter 2022 Financial Results
- Pulse Biosciences Schedules Third Quarter 2022 Financial Results Conference Call for November 10, 2022
- Pulse Biosciences Announces Positive Clinical Data on Nano-Pulse Stimulation Procedure for Low-Risk Basal Cell Carcinoma Lesions
- Pulse Biosciences Announces FDA 510(k) Clearance for the Treatment of Sebaceous Hyperplasia
